ChaiworapongsaTChaemsaithongPYeoLRomeroR. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480.
2.
JeyabalanA. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013;71(suppl 1):S18–S25.
3.
BouçasAPde SouzaBMBauerACCrispimD. Role of innate immunity in preeclampsia: a systematic review. Reprod Sci. 2017;24(10):1362–1370.
4.
PonderKLBárcenaABosFL. Preeclampsia and inflammatory preterm labor alter the human placental hematopoietic niche. Reprod Sci. 2016;23(9):1179–1192.
5.
UchikuraYMatsubaraKMutoY. Extranuclear translocation of high-mobility group a1 reduces the invasion of extravillous trophoblasts involved in the pathogenesis of preeclampsia: new aspect of high-mobility group A1. Reprod Sci. 2017;24(12):1630–1638.
6.
BergmanLÅkerudH. Plasma levels of the cerebral biomarker, neuron-specific enolase, are elevated during pregnancy in women developing preeclampsia. Reprod Sci. 2016;23(3):395–400.
7.
LeFevreML. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(11):819–826.
8.
SaadAFDikenZMKechichianTB. Pravastatin effects on placental prosurvival molecular pathways in a mouse model of preeclampsia. Reprod Sci. 2016;23(11):1593–1599.
9.
DongXShiD. Simvastatin alleviates pathology in a rat model of preeclampsia involving ERK/MAPK Pathway. Reprod Sci. 2017;24(7):1053–1061.
10.
ZhangYZhangBWeiZLLvWJYangYYChenY. Diagnostic significance of phosphoinositide 3-kinase and mammalian target of rapamycin complex 1 in preeclampsia. Reprod Sci. 2017;24(2):268–275.
11.
McCarthyFPDrewloSEnglishFA. Evidence implicating peroxisome proliferator-activated receptor-gamma in the pathogenesis of preeclampsia. Hypertension. 2011;58(5):882–887.
12.
ZhangCZhuYShenYZuoC. Aspirin ameliorates preeclampsia induced by a peroxisome proliferator-activated receptor antagonist. Reprod Sci. 2018;25(12):1655–1662. doi:10.1177/1933719118756746
